FitLife Brands, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US33817P3064
USD
9.32
0.33 (3.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.14 k

Shareholding (Dec 2025)

FII

0.73%

Held by 13 FIIs

DII

93.05%

Held by 6 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Negative results in Sep 25

  • ROCE(HY) Lowest at 17.77%
  • INTEREST COVERAGE RATIO(Q) Lowest at 564.48
  • RAW MATERIAL COST(Y) Grown by 16.54% (YoY)
2

With ROE of 19.04%, it has a fair valuation with a 3.23 Price to Book Value

3

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 135 Million (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.04

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

3.23

Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Dec 2025)
Net Profit:
2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-43.89%
0%
-43.89%
6 Months
-48.28%
0%
-48.28%
1 Year
-30.0%
0%
-30.0%
2 Years
-67.72%
0%
-67.72%
3 Years
-45.18%
0%
-45.18%
4 Years
-12.94%
0%
-12.94%
5 Years
-71.83%
0%
-71.83%

FitLife Brands, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
29.33%
EBIT Growth (5y)
33.79%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.76%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
3.23
EV to EBIT
14.21
EV to EBITDA
14.00
EV to Capital Employed
2.09
EV to Sales
2.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.73%
ROE (Latest)
19.04%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 9 Schemes (6.22%)

Foreign Institutions

Held by 13 Foreign Institutions (0.73%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 10.21% vs 45.96% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 77.78% vs -47.06% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.90",
          "val2": "23.50",
          "chgp": "10.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.70",
          "val2": "3.30",
          "chgp": "-18.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.60",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-0.80",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.60",
          "val2": "0.90",
          "chgp": "77.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "96.30%",
          "val2": "133.60%",
          "chgp": "-3.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 26.36% vs 22.39% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -30.00% vs 69.81% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.50",
          "val2": "64.50",
          "chgp": "26.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.60",
          "val2": "13.50",
          "chgp": "-6.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.40",
          "chgp": "35.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.10",
          "val2": "-0.30",
          "chgp": "-600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.30",
          "val2": "9.00",
          "chgp": "-30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "149.00%",
          "val2": "207.40%",
          "chgp": "-5.84%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
25.90
23.50
10.21%
Operating Profit (PBDIT) excl Other Income
2.70
3.30
-18.18%
Interest
0.80
0.60
33.33%
Exceptional Items
-0.20
-0.80
75.00%
Consolidate Net Profit
1.60
0.90
77.78%
Operating Profit Margin (Excl OI)
96.30%
133.60%
-3.73%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.21% vs 45.96% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 77.78% vs -47.06% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
81.50
64.50
26.36%
Operating Profit (PBDIT) excl Other Income
12.60
13.50
-6.67%
Interest
1.90
1.40
35.71%
Exceptional Items
-2.10
-0.30
-600.00%
Consolidate Net Profit
6.30
9.00
-30.00%
Operating Profit Margin (Excl OI)
149.00%
207.40%
-5.84%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 26.36% vs 22.39% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -30.00% vs 69.81% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details